Related references
Note: Only part of the references are listed.Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic
Jasmina Bojadzieva et al.
FAMILIAL CANCER (2018)
Early detection of metastases using whole-body MRI for initial staging and routine follow-up of myxoid liposarcoma
Natalia Gorelik et al.
SKELETAL RADIOLOGY (2018)
Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors
Michael A. Jacobs et al.
ACADEMIC RADIOLOGY (2018)
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Silke Gillessen et al.
EUROPEAN UROLOGY (2018)
Whole-body MRI versus 18F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis
Danyang Wang et al.
ONCOTARGETS AND THERAPY (2018)
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer
Fabio Zugni et al.
PLOS ONE (2018)
Detection of vertebral metastases: a meta-analysis comparing MRI, CT, PET, BS and BS with SPECT
Tao Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma
Domenico Albano et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2017)
Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer
Katrijn Michielsen et al.
EUROPEAN JOURNAL OF CANCER (2017)
The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer
Michael Kosmin et al.
EUROPEAN JOURNAL OF CANCER (2017)
Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction
Arash Latifoltojar et al.
EUROPEAN RADIOLOGY (2017)
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
Nicolas Mottet et al.
EUROPEAN UROLOGY (2017)
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer
Anwar R. Padhani et al.
EUROPEAN UROLOGY (2017)
Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls
Sibel Saya et al.
FAMILIAL CANCER (2017)
Diagnostic Performance of Different Imaging Modalities in the Assessment of Distant Metastasis and Local Recurrence of Tumor in Patients with Non-Small Cell Lung Cancer
Yoshiharu Ohno et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2017)
Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort
Phuong L. Mai et al.
JAMA ONCOLOGY (2017)
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging A Meta-analysis
Mandy L. Ballinger et al.
JAMA ONCOLOGY (2017)
Whole body MRI for systemic staging of breast cancer in pregnant women
Fedro A. Peccatori et al.
BREAST (2017)
Guidelines for the use of imaging in the management of patients with myeloma
Andrew Chantry et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood
Surya P. Rednam et al.
CLINICAL CANCER RESEARCH (2017)
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Christian P. Kratz et al.
CLINICAL CANCER RESEARCH (2017)
Rationale for Modernising Imaging in Advanced Prostate Cancer
Anwar R. Padhani et al.
EUROPEAN UROLOGY FOCUS (2017)
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial
Ivan Jambor et al.
ACTA ONCOLOGICA (2016)
Risks of First and Subsequent Cancers Among TP53 Mutation Carriers in the National Cancer Institute Li-Fraumeni Syndrome Cohort
Phuong L. Mai et al.
CANCER (2016)
Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.
Domenico Albano et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
Anita Villani et al.
LANCET ONCOLOGY (2016)
Whole-Body MR Imaging: Musculoskeletal Applications
Frederic E. Lecouvet
RADIOLOGY (2016)
The updated Swiss guidelines 2016 for the treatment and follow-up of cutaneous melanoma
Reinhard Dummer et al.
SWISS MEDICAL WEEKLY (2016)
Whole-Body MRI Screening in Asymptomatic Subjects; Preliminary Experience and Long-Term Follow-Up Findings
Sila Ulus et al.
POLISH JOURNAL OF RADIOLOGY (2016)
Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging
Ettore Squillaci et al.
ACTA RADIOLOGICA (2015)
Diagnostic Performance of Whole-Body MRI as a Tool for Cancer Screening in Children With Genetic Cancer-Predisposing Conditions
Sudha A. Anupindi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2015)
Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients
Marius E. Mayerhoefer et al.
CLINICAL CANCER RESEARCH (2015)
Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement
Meletios A. Dimopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Whole-Body MR Imaging in the German National Cohort:Rationale, Design, and Technical Background
Fabian Bamberg et al.
RADIOLOGY (2015)
Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
B. Meller et al.
EJNMMI RESEARCH (2015)
Clinical value of whole-body magnetic resonance imaging in health screening of general adult population
David Laszlo Tarnoki et al.
RADIOLOGY AND ONCOLOGY (2015)
Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients
Marius E. Mayerhoefer et al.
CLINICAL CANCER RESEARCH (2014)
Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: A review and position statement by the European Organisation for Research and Treatment of Cancer imaging group
F. E. Lecouvet et al.
EUROPEAN JOURNAL OF CANCER (2014)
Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: A meta-analysis
Bin Li et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Therapy monitoring of skeletal metastases with whole-body diffusion MRI
Anwar R. Padhani et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2014)
Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study
J. C. Jouvet et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
High-risk prostate cancer-classification and therapy
Albert J. Chang et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Non-Contrast-Enhanced Whole-Body Magnetic Resonance Imaging in the General Population: The Incidence of Abnormal Findings in Patients 50 Years Old and Younger Compared to Older Subjects
Andrzej Cieszanowski et al.
PLOS ONE (2014)
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis
Guohua Shen et al.
SKELETAL RADIOLOGY (2014)
Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas
Velasco Stephane et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma
Julie C. Dutoit et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Potentially relevant incidental findings on research whole-body MRI in the general adult population: frequencies and management
Katrin Hegenscheid et al.
EUROPEAN RADIOLOGY (2013)
Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients?
Giuseppe Petralia et al.
EUROPEAN RADIOLOGY (2013)
Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospective study in 116 patients and comparison with FDG-PET
Hugo J. A. Adams et al.
EUROPEAN RADIOLOGY (2013)
Malignant Melanoma S3-Guideline Diagnosis, Therapy and Follow-up of Melanoma
Annette Pflugfelder et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2013)
Conclusions and future directions for the REiNS International Collaboration
Brigitte C. Widemann et al.
NEUROLOGY (2013)
Whole-body MRI including diffusion-weighted imaging compared to CT for staging of malignant melanoma
Firas Mosavi et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2013)
Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls
Dow-Mu Koh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences
Annemiek B. G. Kwast et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines
Richard T. Hoppe et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Bony metastases: assessing response to therapy with whole-body diffusion MRI
A.R. Padhani et al.
CANCER IMAGING (2012)
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
Colleen M. Costelloe et al.
Journal of Cancer (2012)
Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients
Goran Abdulqadhr et al.
ACTA RADIOLOGICA (2011)
Newly Diagnosed Lymphoma: Initial Results With Whole-Body T1-Weighted, STIR, and Diffusion-Weighted MRI Compared With 18F-FDG PET/CT
Henriette M. E. Quarles van Ufford et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Whole-Body Diffusion-Weighted Imaging: The Added Value to Whole-Body MRI at Initial Diagnosis of Lymphoma
Jing Gu et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology
Jens Hillengass et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy
Hui-Lin Yang et al.
EUROPEAN RADIOLOGY (2011)
Whole-Body Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Treatment Response Assessment in Patients With Diffuse Large B-Cell Lymphoma Pilot Study
Chieh Lin et al.
INVESTIGATIVE RADIOLOGY (2011)
Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma - a pilot study: comparison with 2-deoxy-2-fluoro-D-glucose-positron emission tomography/computed tomography
Xingchen Wu et al.
NMR IN BIOMEDICINE (2011)
Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
Jens Hillengass et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Multiple Myeloma Treatment Response Assessment with Whole-Body Dynamic Contrast-enhanced MR Imaging
Chieh Lin et al.
RADIOLOGY (2010)
Detection of Bone Metastases in Non-Small Cell Lung Cancer Patients: Comparison of Whole-Body Diffusion-Weighted Imaging (DWI), Whole-Body MR Imaging Without and With DWI, Whole-Body FDG-PET/CT, and Bone Scintigraphy
Daisuke Takenaka et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)
Survival Expectations of Patients Diagnosed with Hodgkin's Lymphoma in 2006-2010
Hermann Brenner et al.
ONCOLOGIST (2009)
Patients with Plasma Cell Disorders Examined at Whole-Body Dynamic Contrast-enhanced MR Imaging: Initial Experience
Chieh Lin et al.
RADIOLOGY (2009)
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
[Anonymous]
NEOPLASIA (2009)
Whole-body MRI versus whole-body MDCT for staging of multiple myeloma
Andrea Baur-Melnyk et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Diffusion-weighted MRI in the body: Applications and challenges in oncology
Dow-Mu Koh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications
Ronald Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Extracranial applications of diffusion-weighted magnetic resonance imaging
Harriet C. Thoeny et al.
EUROPEAN RADIOLOGY (2007)
Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma
C Müller-Horvat et al.
EUROPEAN JOURNAL OF CANCER (2006)
High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography - Experience on a 32-channel system
GP Schmidt et al.
INVESTIGATIVE RADIOLOGY (2005)
Full-body cardiovascular and tumor MRI for early detection of disease: Feasibility and initial experience in 298 subjects
SC Goehde et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2005)
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer
U Veronesi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
NS Goldstein
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2002)
Whole-body MRI using a rolling table platform for the detection of bone metastases
TC Lauenstein et al.
EUROPEAN RADIOLOGY (2002)
Share Paper
